Global Immunoglobulin Products market: Trends and Growth (6.84% CAGR) Segments Forecast 2016-2020

About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

Technavio’s analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Complete report details @ https://www.wiseguyreports.com/reports/417265/global-immunoglobulin-products-market-2016-2020

Key vendors
• Baxalta
• Biotest Pharmaceuticals Corp.
• CSL Ltd.
• Grifols SA
• Kedrion SpA
• Octapharma

Other prominent vendors
• Abeona Therapeutics
• Admabiologics
• Anthera
• Beijing Tiantan Biological Products (China)
• Bharat Serums and Vaccines (India)
• Bio Products Laboratory
• China Biologic Products (China)
• Emergent Biosolutions
• Gliknik
• Greencross
• Hansamedical
• Hualan Biological Engineering (China)
• Immunomedics
• Innate Pharma
• Integrated Biotherapeutics
• Janssen Pharmaceuticals
• Kamada
• LFB Group (France)
• Mitsubishi Tanabe Pharma
• Momenta Pharma
• Patrys
• Shanghai RAAS Blood Products (China)
• Sichuan Yuanda Shuyang Pharmaceutical (China)
• Sorrento Therapeutics

Market driver
• Growing aging population
• For a full, detailed list, view our report

Market challenge
• High cost of therapy
• For a full, detailed list, view our report

Market trend
• Patient assistance programs
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/417265/global-immunoglobulin-products-market-2016-2020

TABLE OF CONTENT

PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Plasma products: An overview
• Components of blood plasma
• Manufacturing process of plasma products
• Clinical uses of plasma
• Cost of plasma therapeutics
PART 06: Regulation of plasma products
PART 07: Pipeline portfolio
• Information on few pipeline candidates
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by type of immunoglobulins
PART 10: Market segmentation by application
• Immunodeficiency diseases
• Hypogammaglobulinemia
• CIDP
• Congenital AIDS
• CLL
• Myasthenia gravis
• MMN
• ITP
• Kawasaki disease
• Guillain–Barré syndrome
• Others
PART 11: Market segmentation by ROA
• IVIG products
• SCIG products
• IMIG products
PART 12: Market segmentation by volume
• Market overview
• Immunoglobulin products market by volume in Americas
• Immunoglobulin products market by volume in EMEA
• Immunoglobulin products market by volume in APAC
PART 13: Geographical segmentation
• Immunoglobulin products market in Americas
• Immunoglobulin products market in EMEA
• Immunoglobulin products market in APAC
PART 14: Market drivers
• Growing older population
• Increase in individuals with PID
• Promising pipeline
• Approval of immunoglobulins to treat neuroimmunological disorders
• Rise in demand for IVIG therapies
PART 15: Impact of drivers
PART 16: Market challenges
• High cost of therapy
• Product recalls by US FDA
• Limited plasma fractionation capacity
• Post-transfusion adverse reactions
• Stringent regulatory guidelines
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Patient assistance programs
• Strategic alliances and M&A
• Increased use of synthetic/recombinant products
• Rise in awareness of PID
PART 19: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• CSL
• Baxalta
• Grifols
• Octapharma
• Kedrion
• Biotest Pharmaceuticals
• Other prominent vendors
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio 

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=417265

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)